MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 2 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,466,000 | -22.3% | 46,500 | -25.0% | 0.25% | -22.2% |
| Q2 2022 | $1,886,000 | -31.9% | 62,000 | -56.9% | 0.32% | -46.8% |
| Q3 2021 | $2,771,000 | -13.2% | 144,000 | 0.0% | 0.61% | -7.7% |
| Q2 2021 | $3,194,000 | -15.5% | 144,000 | 0.0% | 0.66% | -14.9% |
| Q1 2021 | $3,780,000 | +58.0% | 144,000 | +12.5% | 0.78% | +24.1% |
| Q4 2020 | $2,392,000 | +176.2% | 128,000 | +151.0% | 0.63% | +173.8% |
| Q3 2020 | $866,000 | +551.1% | 51,000 | +580.0% | 0.23% | +1981.8% |
| Q3 2014 | $133,000 | -14.2% | 7,500 | 0.0% | 0.01% | -8.3% |
| Q2 2014 | $155,000 | -52.6% | 7,500 | -50.0% | 0.01% | -52.0% |
| Q1 2014 | $327,000 | +23.4% | 15,000 | +50.0% | 0.02% | +31.6% |
| Q4 2013 | $265,000 | -10.5% | 10,000 | -20.0% | 0.02% | +18.8% |
| Q3 2013 | $296,000 | +10.0% | 12,500 | 0.0% | 0.02% | +33.3% |
| Q2 2013 | $269,000 | – | 12,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |